Abla, N., Almond, L. M., Bonner, J. J., Richardson, N., Wells, T. N. C., & Möhrle, J. J. (2024). PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies. CTS: Clinical & Translational Science, 17(7), 1. https://doi.org/10.1111/cts.13865
Chicago Style (17th ed.) CitationAbla, Nada, Lisa M. Almond, Jennifer J. Bonner, Naomi Richardson, Timothy N. C. Wells, and Jörg J. Möhrle. "PBPK‐led Assessment of Antimalarial Drugs as Candidates for Covid‐19: Simulating Concentrations at the Site of Action to Inform Repurposing Strategies." CTS: Clinical & Translational Science 17, no. 7 (2024): 1. https://doi.org/10.1111/cts.13865.
MLA (9th ed.) CitationAbla, Nada, et al. "PBPK‐led Assessment of Antimalarial Drugs as Candidates for Covid‐19: Simulating Concentrations at the Site of Action to Inform Repurposing Strategies." CTS: Clinical & Translational Science, vol. 17, no. 7, 2024, p. 1, https://doi.org/10.1111/cts.13865.